Intercure (INCR) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.014x

Based on the latest financial reports, Intercure (INCR) has a cash flow conversion efficiency ratio of 0.014x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA6.10 Million ≈ $16.35K USD) by net assets (ILA432.24 Million ≈ $1.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Intercure - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Intercure's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Intercure (INCR) financial obligations for a breakdown of total debt and financial obligations.

Intercure Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intercure ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Xilio Development Inc NASDAQ:XLO	2.161x
360 Capital Mortgage REIT AU:TCF	-0.287x
Reckon Ltd AU:RKN	0.538x
dMY Squared Technology Group Inc NYSE MKT:DMYY	1.695x
RIT Capital Partners LSE:RCP	0.020x
Coda Minerals Ltd AU:COD	-0.089x
Ekadharma International Tbk JK:EKAD	0.029x
Gamehaus Holdings Inc. Class A Ordinary Shares NASDAQ:GMHS	-0.015x

Annual Cash Flow Conversion Efficiency for Intercure (2010–2024)

The table below shows the annual cash flow conversion efficiency of Intercure from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Intercure (INCR) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA397.67 Million ≈ $1.07 Million	ILA-66.93 Million ≈ $-179.43K	-0.168x	-43.43%
2023-12-31	ILA457.06 Million ≈ $1.23 Million	ILA-53.63 Million ≈ $-143.78K	-0.117x	-219.35%
2022-12-31	ILA521.48 Million ≈ $1.40 Million	ILA51.27 Million ≈ $137.45K	0.098x	+80.43%
2021-12-31	ILA459.19 Million ≈ $1.23 Million	ILA25.02 Million ≈ $67.08K	0.054x	+103.97%
2020-12-31	ILA292.11 Million ≈ $783.13K	ILA7.80 Million ≈ $20.92K	0.027x	+270.54%
2019-12-31	ILA256.20 Million ≈ $686.87K	ILA-4.01 Million ≈ $-10.76K	-0.016x	+79.27%
2018-12-31	ILA19.66 Million ≈ $52.71K	ILA-1.49 Million ≈ $-3.98K	-0.076x	-69.69%
2017-12-31	ILA20.68 Million ≈ $55.44K	ILA-921.03K ≈ $-2.47K	-0.045x	+8.33%
2016-12-31	ILA24.07 Million ≈ $64.53K	ILA-1.17 Million ≈ $-3.14K	-0.049x	+65.72%
2015-12-31	ILA11.95 Million ≈ $32.05K	ILA-1.69 Million ≈ $-4.54K	-0.142x	+94.79%
2014-12-31	ILA697.01K ≈ $1.87K	ILA-1.90 Million ≈ $-5.08K	-2.721x	-220.50%
2013-12-31	ILA3.92 Million ≈ $10.50K	ILA-3.33 Million ≈ $-8.92K	-0.849x	-433.44%
2012-12-31	ILA9.84 Million ≈ $26.37K	ILA-1.57 Million ≈ $-4.20K	-0.159x	-1056.85%
2011-12-31	ILA-51.72 Million ≈ $-138.66K	ILA-860.16K ≈ $-2.31K	0.017x	-93.72%
2010-12-31	ILA-12.03 Million ≈ $-32.26K	ILA-3.19 Million ≈ $-8.54K	0.265x	--

About Intercure

TA:INCR Israel Drug Manufacturers - Specialty & Generic

Market Cap

$36.85 Million

ILA13.75 Billion ILA

Market Cap Rank

#22982 Global

#329 in Israel

Share Price

ILA251.40

Change (1 day)

-0.08%

52-Week Range

ILA228.00 - ILA585.00

All Time High

ILA6317.95